請更新您的瀏覽器

您使用的瀏覽器版本較舊,已不再受支援。建議您更新瀏覽器版本,以獲得最佳使用體驗。

Eng

Johnson & Johnson COVID-19 vaccine no longer available in U.S.

XINHUA

發布於 2023年05月15日20:10 • Tan Jingjing
廣告(請繼續閱讀本文)

A health worker administers a COVID-19 vaccine shot to a local resident in Los Angeles, the United States, on Dec. 17, 2022. (Xinhua)

All remaining U.S. government stock of the Johnson & Johnson vaccine expired May 7, according to the CDC.

LOS ANGELES, May 15 (Xinhua) -- Johnson & Johnson COVID-19 vaccine is no longer available in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).

All remaining U.S. government stock of the Johnson & Johnson vaccine expired May 7, according to a post on the CDC website.

The agency has directed providers to dispose of any remaining stock in accordance with local, state and federal regulations.

People aged 18 and older who received 1 or 2 Johnson & Johnson COVID-19 vaccine dose are recommended to receive 1 bivalent mRNA dose of Moderna or Pfizer-BioNTech at least 2 months after completion of the previous dose, said the CDC.

More than 19 million doses of the Johnson & Johnson COVID-19 vaccine were administered in the United States as of May 11, according to the latest CDC data. ■